Mehow Innovative Valuation Multiples

Mehow Innovative is valued at $1.8B as of October 2026, a 5.6x revenue multiple. In the last 12 months, Mehow Innovative revenue was $280M and Mehow Innovative EBITDA was $73M.

Mehow Innovative Overview

About Mehow Innovative

Mehow Innovative Ltd is engaged in the design, development, manufacture and sales of precision components and products for medical devices.


Founded

2010

HQ

China

Employees

N/A

Website

mehow.com

Financials (LTM)

Revenue: $280M
EBITDA: $73M

EV

$1.6B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Mehow Innovative Financials

Mehow Innovative reported last 12-month revenue of $280M and EBITDA of $73M.

In the same LTM period, Mehow Innovative generated $114M in gross profit, $73M in EBITDA, and $50M in net income.

Revenue (LTM)


Mehow Innovative P&L

In the most recent fiscal year, Mehow Innovative reported revenue of $243M and EBITDA of $57M.

Mehow Innovative is profitable as of last fiscal year, with gross margin of 40%, EBITDA margin of 24%, and net margin of 17%.

See analyst estimates for Mehow Innovative
LTMLast FY202320242025202620272028
Revenue$280M$243M$198M$236M$243M
Gross Profit$114M$98M$82M$99M$98M
Gross Margin41%40%41%42%40%
EBITDA$73M$57M$65M$75M$57M
EBITDA Margin26%24%33%32%24%
EBIT Margin20%21%23%23%21%
Net Profit$50M$42M$46M$54M$42M
Net Margin18%17%23%23%17%
Net Debt-($201M)---

Financial data powered by Morningstar, Inc.

Mehow Innovative Stock Performance

Mehow Innovative has current market cap of $1.8B, and enterprise value of $1.6B.

Market Cap Evolution


Mehow Innovative's stock price is $2.24.

Mehow Innovative share price decreased by 7.7% in the last 30 days, and by 5.3% in the last year.

Mehow Innovative has an EPS (earnings per share) of $0.05.

See more trading valuation data for Mehow Innovative
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.6B$1.8B0.3%-7.7%-4.3%-5.3%$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Mehow Innovative Valuation Multiples

Mehow Innovative trades at 5.6x EV/Revenue multiple, and 21.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Mehow Innovative

EV / Revenue (LTM)


Mehow Innovative Financial Valuation Multiples

As of October 20, 2026, Mehow Innovative has market cap of $1.8B and EV of $1.6B.

Mehow Innovative has a P/E ratio of 36.0x.

LTMLast FY202320242025202620272028
EV/Revenue5.6x6.4x7.9x6.6x6.4x
EV/EBITDA21.4x27.1x23.9x20.6x27.1x
EV/EBIT27.5x30.7x34.6x28.2x30.7x
EV/Gross Profit13.7x16.0x19.1x15.7x16.0x
P/E36.0x42.0x38.3x33.0x42.0x
EV/FCF81.7x(95.0x)114.7x123.4x(95.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Mehow Innovative Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Mehow Innovative Margins & Growth Rates

Mehow Innovative grew revenue by 19% and EBITDA by 32% in the last fiscal year.

In the most recent fiscal year, Mehow Innovative reported gross margin of 40%, EBITDA margin of 24%, and net margin of 17%.

See estimated margins and future growth rates for Mehow Innovative

Mehow Innovative Margins

Last FY202420252026202720282029
Gross Margin40%42%40%41%
EBITDA Margin24%32%24%26%
EBIT Margin21%23%21%20%
Net Margin17%23%17%18%
FCF Margin(7%)5%(7%)-

Mehow Innovative Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth19%19%3%19%
Gross Profit Growth21%22%(2%)21%
EBITDA Growth32%16%(24%)32%
EBIT Growth16%23%(8%)16%
Net Profit Growth21%16%(21%)21%
FCF Growth-(7%)(230%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Mehow Innovative Operational KPIs

Mehow Innovative's Rule of 40 is 45% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Mehow Innovative's Rule of X is 74% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Mehow Innovative
LTMLast FY202320242025202620272028
Rule of 4046%45%---
Bessemer Rule of X77%74%---
S&M Expenses to Revenue3%1%1%1%1%
G&A Expenses to Revenue8%1%2%2%1%
R&D Expenses to Revenue9%8%9%9%8%
Opex to Revenue-19%18%19%19%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Mehow Innovative Competitors

Mehow Innovative competitors include Embla Medical, Draegerwerk, Alamar Biosciences, Establishment Labs, Jafron Biomedical, NovoCure, Cofoe Medical, Fukuda Denshi, Insight Lifetech and Qingdao Baheal Medical.

Most Mehow Innovative public comparables operate across Medical Devices, DeepTech and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Embla Medical$929M$187M2.4x2.2x11.7x10.7x
Draegerwerk$3.9B$438M0.5x0.5x4.4x4.4x
Alamar Biosciences$74M($27M)21.9x14.8x(60.1x)(34.2x)
Establishment Labs$211M($23M)9.1x7.5x(84.9x)160.4x
Jafron Biomedical$301M$123M5.5x5.3x13.4x11.4x
NovoCure$655M($117M)2.3x2.1x(13.0x)364.1x
Cofoe Medical$507M$90M2.8x2.3x15.6x13.8x
Fukuda Denshi$883M$246M1.6x1.6x5.8x-

This data is available for Pro users. Sign up to see all Mehow Innovative competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Mehow Innovative

When was Mehow Innovative founded?Mehow Innovative was founded in 2010.
Where is Mehow Innovative headquartered?Mehow Innovative is headquartered in China.
Is Mehow Innovative publicly listed?Yes, Mehow Innovative is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Mehow Innovative?Mehow Innovative trades under 301363 ticker.
When did Mehow Innovative go public?Mehow Innovative went public in 2022.
Who are competitors of Mehow Innovative?Mehow Innovative main competitors include Embla Medical, Draegerwerk, Alamar Biosciences, Establishment Labs, Jafron Biomedical, NovoCure, Cofoe Medical, Fukuda Denshi, Insight Lifetech, Qingdao Baheal Medical.
What is the current market cap of Mehow Innovative?Mehow Innovative's current market cap is $1.8B.
What is the current revenue of Mehow Innovative?Mehow Innovative's last 12 months revenue is $280M.
What is the current revenue growth of Mehow Innovative?Mehow Innovative revenue growth (NTM/LTM) is 20%.
What is the current EV/Revenue multiple of Mehow Innovative?Current revenue multiple of Mehow Innovative is 5.6x.
What is the current EBITDA of Mehow Innovative?Mehow Innovative's last 12 months EBITDA is $73M.
What is Mehow Innovative's EBITDA margin?Mehow Innovative's last 12 months EBITDA margin is 26%.
What is the current EV/EBITDA multiple of Mehow Innovative?Current EBITDA multiple of Mehow Innovative is 21.4x.
What is the current FCF of Mehow Innovative?Mehow Innovative's last 12 months FCF is $19M.
What is Mehow Innovative's FCF margin?Mehow Innovative's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Mehow Innovative?Current FCF multiple of Mehow Innovative is 81.7x.
How many companies Mehow Innovative has acquired to date?Mehow Innovative hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Mehow Innovative has invested to date?Mehow Innovative hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Mehow Innovative

Lists including Mehow Innovative

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial